VYNE THERAPEUTICS INC's ticker is VYNE and the CUSIP is 92941V209. A total of 57 filers reported holding VYNE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $0 | – | 774 | +20.0% | 0.00% | – |
| Q3 2022 | $0 | – | 645 | +2704.3% | 0.00% | – |
| Q2 2022 | $0 | – | 23 | -93.7% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 367 | -51.1% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 750 | -38.2% | 0.00% | – |
| Q3 2021 | $1,000 | -92.3% | 1,214 | -67.9% | 0.00% | – |
| Q2 2021 | $13,000 | -45.8% | 3,780 | +6.0% | 0.00% | – |
| Q1 2021 | $24,000 | – | 3,565 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 400,000 | $2,738,000 | 6.10% |
| DSC Advisors, L.P. | 1,038,145 | $7,106,000 | 4.40% |
| CM Management, LLC | 143,750 | $984,000 | 0.73% |
| Perceptive Advisors | 6,773,954 | $46,368,000 | 0.59% |
| DELTEC ASSET MANAGEMENT LLC | 441,491 | $3,022,000 | 0.45% |
| Perennial Investment Advisors, LLC | 35,000 | $240,000 | 0.10% |
| Tekla Capital Management LLC | 135,395 | $927,000 | 0.03% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 10,051 | $69,000 | 0.02% |
| AXA S.A. | 882,124 | $6,038,000 | 0.02% |
| STALEY CAPITAL ADVISERS INC | 25,000 | $171,000 | 0.01% |